1. Executive Summary |
2. Global Bone Substitutes and Bone Allografts Market Introduction |
2.1. Global Bone Substitutes and Bone Allografts Market – Taxonomy |
2.2. Global Bone Substitutes and Bone Allografts Market –Definitions |
2.2.1. Product |
2.2.2. Application |
3. Global Bone Substitutes and Bone Allografts Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Bone Substitutes and Bone Allografts Market Dynamic Factors – Impact Analysis |
3.6. Global Bone Substitutes and Bone Allografts Market – Competition Landscape |
4. Global Bone Substitutes and Bone Allografts Market Analysis,2017 – 2021 and Forecast, 2022 – 2028 |
4.1. Market Analysis,2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Bone Substitutes and Bone Allografts Market, By Product, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1. Bone Substitutes |
5.1.1. Hydroxyapatites (HAp) |
5.1.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.1.3. Market Opportunity Analysis |
5.1.2. Calcium Phosphate |
5.1.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.2.3. Market Opportunity Analysis |
5.1.3. Calcium Sulphate |
5.1.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3.3. Market Opportunity Analysis |
5.1.4. Bioactive Glass |
5.1.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.4.3. Market Opportunity Analysis |
5.2. Bone Allografts |
5.2.1. Freeze Dried |
5.2.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.1.3. Market Opportunity Analysis |
5.2.2. Demineralized Bone Matrix |
5.2.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.2.3. Market Opportunity Analysis |
5.2.3. Tendon Allografts |
5.2.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3.3. Market Opportunity Analysis |
5.2.4. Synthetic Tendon Grafts |
5.2.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.2.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.4.3. Market Opportunity Analysis |
6. Global Bone Substitutes and Bone Allografts Market, By Application, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.1. Spinal Fusion |
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Long Bone |
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Foot and Ankle |
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Craniomaxillofacial |
6.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Joint Reconstruction |
6.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
6.6. Dental Bone Grafting |
6.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.6.3. Market Opportunity Analysis |
6.7. Others |
6.7.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.7.3. Market Opportunity Analysis |
7. Global Bone Substitutes and Bone Allografts Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.1. North America |
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia-Pacific |
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Latin America |
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Middle East and Africa |
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
7.6. Global Bone Substitutes and Bone Allografts Market – Opportunity Analysis Index, By Product, Application and Region, 2022 – 2028 |
8. North America Bone Substitutes and Bone Allografts MarketAnalysis,2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
8.1. By Product Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
8.1.1. Bone Substitutes |
8.1.1.1. Hydroxyapatites (HAp) |
8.1.1.2. Calcium Phosphate |
8.1.1.3. Calcium Sulphate |
8.1.1.4. Bioactive Glass |
8.1.2. Bone Allografts |
8.1.2.1. Freeze Dried |
8.1.2.2. Demineralized Bone Matrix |
8.1.2.3. Tendon Allografts |
8.1.2.4. Synthetic Tendon Grafts |
8.2. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
8.2.1.1. Spinal Fusion |
8.2.1.2. Long Bone |
8.2.1.3. Foot and Ankle |
8.2.1.4. Craniomaxillofacial |
8.2.1.5. Joint Reconstruction |
8.2.1.6. Dental Bone Grafting |
8.2.1.7. Others |
8.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
8.3.1. USA |
8.3.2. Canada |
8.4. North America Bone Substitutes and Bone Allografts Market – Opportunity Analysis Index, By Product, Application, and Country, 2022 – 2028 |
8.5. North America Bone Substitutes and Bone Allografts Market Dynamics – Trends |
9. Europe Bone Substitutes and Bone Allografts Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
9.1. By Product Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
9.1.1. Bone Substitutes |
9.1.1.1. Hydroxyapatites (HAp) |
9.1.1.2. Calcium Phosphate |
9.1.1.3. Calcium Sulphate |
9.1.1.4. Bioactive Glass |
9.1.2. Bone Allografts |
9.1.2.1. Freeze Dried |
9.1.2.2. Demineralized Bone Matrix |
9.1.2.3. Tendon Allografts |
9.1.2.4. Synthetic Tendon Grafts |
9.2. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
9.2.1.1. Spinal Fusion |
9.2.1.2. Long Bone |
9.2.1.3. Foot and Ankle |
9.2.1.4. Craniomaxillofacial |
9.2.1.5. Joint Reconstruction |
9.2.1.6. Dental Bone Grafting |
9.2.1.7. Others |
9.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
9.3.1. Germany |
9.3.2. UK |
9.3.3. France |
9.3.4. Spain |
9.3.5. Italy |
9.3.6. Russia |
9.3.7. Poland |
9.3.8. Rest of Europe |
9.4. Europe Bone Substitutes and Bone Allografts Market – Opportunity Analysis Index, By Product, Application, and Country, 2022 – 2028 |
9.5. Europe Bone Substitutes and Bone Allografts Market Dynamics – Trends |
10. Asia-Pacific Bone Substitutes and Bone Allografts Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
10.1. By Product Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Bone Substitutes |
10.1.1.1. Hydroxyapatites (HAp) |
10.1.1.2. Calcium Phosphate |
10.1.1.3. Calcium Sulphate |
10.1.1.4. Bioactive Glass |
10.1.2. Bone Allografts |
10.1.2.1. Freeze Dried |
10.1.2.2. Demineralized Bone Matrix |
10.1.2.3. Tendon Allografts |
10.1.2.4. Synthetic Tendon Grafts |
10.2. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.2.1.1. Spinal Fusion |
10.2.1.2. Long Bone |
10.2.1.3. Foot and Ankle |
10.2.1.4. Craniomaxillofacial |
10.2.1.5. Joint Reconstruction |
10.2.1.6. Dental Bone Grafting |
10.2.1.7. Others |
10.3. Country Analysis2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Japan |
10.3.2. China |
10.3.3. India |
10.3.4. ASEAN |
10.3.5. Australia & New Zealand |
10.3.6. Rest of Asia-Pacific |
10.4. Asia-Pacific Bone Substitutes and Bone Allografts Market – Opportunity Analysis Index, By Product, Application, and Country, 2022 – 2028 |
10.5. Asia-Pacific Bone Substitutes and Bone Allografts Market Dynamics – Trends |
11. Latin America Bone Substitutes and Bone Allografts Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
11.1. By Product Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Bone Substitutes |
11.1.1.1. Hydroxyapatites (HAp) |
11.1.1.2. Calcium Phosphate |
11.1.1.3. Calcium Sulphate |
11.1.1.4. Bioactive Glass |
11.1.2. Bone Allografts |
11.1.2.1. Freeze Dried |
11.1.2.2. Demineralized Bone Matrix |
11.1.2.3. Tendon Allografts |
11.1.2.4. Synthetic Tendon Grafts |
11.2. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.2.1.1. Spinal Fusion |
11.2.1.2. Long Bone |
11.2.1.3. Foot and Ankle |
11.2.1.4. Craniomaxillofacial |
11.2.1.5. Joint Reconstruction |
11.2.1.6. Dental Bone Grafting |
11.2.1.7. Others |
11.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Brazil |
11.3.2. Mexico |
11.3.3. Argentina |
11.3.4. Rest of Latin America |
11.4. Latin America Bone Substitutes and Bone Allografts Market – Opportunity Analysis Index, By Product, Application, and Country, 2022 – 2028 |
11.5. Latin America Bone Substitutes and Bone Allografts Market Dynamics – Trends |
12. Middle East and Africa Bone Substitutes and Bone Allografts Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
12.1. By Product Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Bone Substitutes |
12.1.1.1. Hydroxyapatites (HAp) |
12.1.1.2. Calcium Phosphate |
12.1.1.3. Calcium Sulphate |
12.1.1.4. Bioactive Glass |
12.1.2. Bone Allografts |
12.1.2.1. Freeze Dried |
12.1.2.2. Demineralized Bone Matrix |
12.1.2.3. Tendon Allografts |
12.1.2.4. Synthetic Tendon Grafts |
12.2. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.2.1.1. Spinal Fusion |
12.2.1.2. Long Bone |
12.2.1.3. Foot and Ankle |
12.2.1.4. Craniomaxillofacial |
12.2.1.5. Joint Reconstruction |
12.2.1.6. Dental Bone Grafting |
12.2.1.7. Others |
12.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Gulf Cooperation Council (GCC) Countries |
12.3.2. Israel |
12.3.3. South Africa |
12.3.4. Rest of MEA |
12.4. MEA Bone Substitutes and Bone Allografts Market – Opportunity Analysis Index, By Product, Application, and Country, 2022 – 2028 |
12.5. MEA Bone Substitutes and Bone Allografts Market Dynamics – Trends |
13. Competition Landscape |
13.1. Strategic Dashboard of Top Market Players |
13.2. Company Profiles (Introduction, Financial Analysis, Technology & Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
13.2.1. AlloSource |
13.2.2. Baxter |
13.2.3. DEPUY SYNTHES |
13.2.4. INTEGRA LIFESCIENCES HOLDINGS CORPORATION |
13.2.5. Medtronic |
13.2.6. NuVasive, Inc. |
13.2.7. Orthovita, Inc. |
13.2.8. Smith and Nephew Inc. |
13.2.9. Stryker Corporation |
13.2.10. Wright Medical Group N.V |
13.2.11. ZIMMER BIOMET |
14. Research Methodology |
15. Key Assumptions and Acronyms |